SCHEMBL14720634

SCHEMBL14720634

O=C(NCc1ccc(C=C2CCN(C3CCC3)CC2)cc1)C1CCOC1

nearest known ligand 0.39

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.39
USP2 O75604 1/20 0.39
HPGD P15428 1/20 0.39
KMT2A Q03164 1/20 0.39
HRH3 Q9Y5N1 4/20 0.39
MAPT P10636 2/20 0.38
TSHR P16473 1/20 0.37
GAA P10253 1/20 0.37
HTR1A P08908 1/20 0.37
DRD2 P14416 1/20 0.37
DRD4 P21917 1/20 0.37
GLA P06280 1/20 0.37
SRD5A2 P31213 1/20 0.36
LMNA P02545 1/20 0.36
HTT P42858 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
CYP3A4 P08684 1/20 0.36
CYP2C9 P11712 1/20 0.36
CYP2C19 P33261 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14720886 0.87 ALDH1A1 (0.50) ALDH1A1USP2HPGDKMT2AHRH3
SCHEMBL1788940 0.82 HRH3 (0.44) ALDH1A1USP2HPGDHRH3TSHR
SCHEMBL14720817 0.79 SRD5A2 (0.43) ALDH1A1KMT2AHRH3SRD5A2LMNA
SCHEMBL14731157 0.77 SRD5A2 (0.37) ALDH1A1HPGDKMT2AHRH3TSHR
SCHEMBL14720514 0.76 NAMPT (0.47) HRH3
SCHEMBL1792091 0.75 HRH3 (0.48) ALDH1A1USP2HPGDKMT2AHRH3
SCHEMBL14722982 0.74 SRD5A2 (0.38) HRH3SRD5A2
SCHEMBL14720412 0.74 NAMPT (0.44) KMT2AHRH3GAASRD5A2SMN1; SMN2
SCHEMBL14721067 0.73 SRD5A2 (0.42) ALDH1A1HPGDHRH3SRD5A2
SCHEMBL14721400 0.72 SRD5A2 (0.48) ALDH1A1KMT2AHRH3TSHRSRD5A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2013027001-A1 COMPOUNDS AND THEIR USE TO TREAT HISTAMINE H3 RELATED DISORDERS TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2013-02-28 WO claimed
WO-2013027001-A1 COMPOUNDS AND THEIR USE TO TREAT HISTAMINE H3 RELATED DISORDERS TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2013-02-28 WO disclosed
WO-2013027001-A1 COMPOUNDS AND THEIR USE TO TREAT HISTAMINE H3 RELATED DISORDERS TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2013-02-28 WO disclosed